Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer

  Free Subscription


Articles published in Int J Gynecol Cancer

Retrieve available abstracts of 296 articles:
HTML format



Single Articles


    September 2021
  1. SCHMELER KM, Pareja R, Lopez Blanco A, Humberto Fregnani J, et al
    ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer.
    Int J Gynecol Cancer. 2021 Sep 7. pii: ijgc-2021-002921.
    PubMed     Abstract available


    August 2021
  2. LUVIAN-MORALES J, Flores-Cisneros L, Jimenez-Lima R, Alarcon-Barrios S, et al
    Validation of the QLQ-CX24 questionnaire for the assessment of quality of life in Mexican women with cervical cancer.
    Int J Gynecol Cancer. 2021 Aug 5. pii: ijgc-2021-002720.
    PubMed     Abstract available


    July 2021
  3. BORIA F, Chiva L, Zanagnolo V, Querleu D, et al
    Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators.
    Int J Gynecol Cancer. 2021 Jul 28. pii: ijgc-2021-002587.
    PubMed     Abstract available


  4. GROVER S, Ning MS, Bale M, Lichter KE, et al
    Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
    Int J Gynecol Cancer. 2021 Jul 26. pii: ijgc-2021-002601.
    PubMed     Abstract available


  5. SPENCER NM, Bos L
    Intracardiac metastatic cervical cancer.
    Int J Gynecol Cancer. 2021;31:1095.
    PubMed    


    June 2021
  6. CHILINDA G, Massamba L, Meja S, Ngo C, et al
    Implementing a comprehensive cervical cancer program in Southern Malawi: a 'Medecins Sans Frontieres', Ministry of Health, and College of Medicine of Blantyre Collaborative Project.
    Int J Gynecol Cancer. 2021 Jun 2. pii: ijgc-2021-002743.
    PubMed    


    May 2021
  7. MANZOUR N, Vazquez-Vicente D, Carriles I, Boria F, et al
    Intra-operative radiation therapy after a total lateral extended infralevator exenteration for recurrent cervical cancer.
    Int J Gynecol Cancer. 2021 May 24. pii: ijgc-2021-002592.
    PubMed    


  8. MATSUO K, Nusbaum DJ, Matsuzaki S, Klar M, et al
    Utilization and outcomes of adjuvant systemic chemotherapy alone in high risk, early stage cervical cancer in the United States.
    Int J Gynecol Cancer. 2021 May 20. pii: ijgc-2021-002655.
    PubMed     Abstract available


  9. KUMAR D, Miriyala R, Rai B, Bansal P, et al
    Impact of three-dimensional chemoradiation on pelvic bone mineral density, low back pain, and disability in cervical cancer: a prospective study.
    Int J Gynecol Cancer. 2021 May 11. pii: ijgc-2020-002290.
    PubMed     Abstract available


  10. WRIGHT JD
    Minimal risk for minimally invasive hysterectomy for stage IA cervical cancer?
    Int J Gynecol Cancer. 2021 May 10. pii: ijgc-2021-002733.
    PubMed    


  11. GOMEZ RODRIGO S, Calderon J, Dionisi JN, Santi A, et al
    Cervical cancer in pregnancy at various gestational ages.
    Int J Gynecol Cancer. 2021;31:784-788.
    PubMed    


    April 2021
  12. MAENE C, Salihi RR, Van Nieuwenhuysen E, Han SN, et al
    Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB-IIB cervical cancer.
    Int J Gynecol Cancer. 2021 Apr 15. pii: ijgc-2021-002432.
    PubMed     Abstract available


  13. CORINTI M, Alvarenga-Bezerra V, Ribeiro R, Liao AW, et al
    Extraperitoneal laparoscopic pelvic lymphadenectomy for cervical cancer staging in twin pregnancy.
    Int J Gynecol Cancer. 2021 Apr 13. pii: ijgc-2021-002410.
    PubMed    


    March 2021
  14. CIBULA D
    Rationale for the avoidance of parametrectomy and systematic lymphadenectomy in patients with early stages of neuroendocrine cervical cancer.
    Int J Gynecol Cancer. 2021 Mar 18. pii: ijgc-2021-002510.
    PubMed    


  15. SORMANI J, Datchoua AM, Petignat P, Kenfack B, et al
    Effects of the COVID-19 pandemic on an urban cervical cancer screening program in West Cameroon.
    Int J Gynecol Cancer. 2021 Mar 12. pii: ijgc-2021-002555.
    PubMed    


  16. FURUSAWA A, Takekuma M, Mori K, Usami T, et al
    A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).
    Int J Gynecol Cancer. 2021 Mar 4. pii: ijgc-2020-002344.
    PubMed     Abstract available


  17. LOPEZ A, Rodriguez J, Estrada E, Aragona A, et al
    Neoadjuvant chemotherapy in pregnant patients with cervical cancer: a Latin-American multicenter study.
    Int J Gynecol Cancer. 2021;31:468-474.
    PubMed     Abstract available


  18. MARTINELLI F, Ditto A, Filippi F, Vinti D, et al
    Conization and lymph node evaluation as a fertility-sparing treatment for early stage cervical cancer.
    Int J Gynecol Cancer. 2021;31:457-461.
    PubMed     Abstract available


  19. FANFANI F, Pedone Anchora L, Di Martino G, Bizzarri N, et al
    Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer.
    Int J Gynecol Cancer. 2021;31:452-456.
    PubMed     Abstract available


  20. NICA A, Marchocki Z, Gien LT, Kupets R, et al
    Cervical conization and lymph node assessment for early stage low-risk cervical cancer.
    Int J Gynecol Cancer. 2021;31:447-451.
    PubMed     Abstract available


  21. NOLL F, Palacios Torres AT, Pecci P, Lucchini SM, et al
    Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
    Int J Gynecol Cancer. 2021;31:379-386.
    PubMed     Abstract available


  22. BUONOMO B, Multinu F, Casarin J, Betella I, et al
    Ovarian transposition in patients with cervical cancer prior to pelvic radiotherapy: a systematic review.
    Int J Gynecol Cancer. 2021;31:360-370.
    PubMed     Abstract available


    February 2021
  23. CAMPITELLI M, Lazzari R, Piccolo F, Ferrazza P, et al
    Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review.
    Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2020-002310.
    PubMed     Abstract available


  24. MCCORMACK M, Gaffney D, Tan D, Bennet K, et al
    The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries.
    Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2021-002422.
    PubMed     Abstract available


  25. SCOTT AA, Yarney J, Vanderpuye V, Akoto Aidoo C, et al
    Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation.
    Int J Gynecol Cancer. 2021 Feb 8. pii: ijgc-2020-002120.
    PubMed     Abstract available


    January 2021
  26. RODRIGUEZ J, Rauh-Hain JA, Saenz J, Isla DO, et al
    Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis.
    Int J Gynecol Cancer. 2021 Jan 27. pii: ijgc-2020-002086.
    PubMed     Abstract available


    December 2020
  27. CAO L, Wen H, Feng Z, Han X, et al
    Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
    Int J Gynecol Cancer. 2020 Dec 10. pii: ijgc-2020-001974.
    PubMed     Abstract available


  28. KIM N, Choi SH, Chang JS, Kim YT, et al
    Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer.
    Int J Gynecol Cancer. 2020 Dec 3. pii: ijgc-2020-002031.
    PubMed     Abstract available


  29. MARNITZ S, Tsunoda AT, Martus P, Vieira M, et al
    Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
    Int J Gynecol Cancer. 2020;30:1855-1861.
    PubMed     Abstract available


    November 2020
  30. RENDON GJ, Lopez Blanco A, Aragona A, Saadi JM, et al
    Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer >/=2 cm.
    Int J Gynecol Cancer. 2020 Nov 16. pii: ijgc-2020-002076.
    PubMed     Abstract available


  31. OLTHOF EP, Mom CH, van der Velden J
    More attention is needed for the corrigendum to the revised FIGO staging for carcinoma of the cervix uteri.
    Int J Gynecol Cancer. 2020;30:1850.
    PubMed    


    October 2020
  32. SANTORO A, Angelico G, Inzani F, Arciuolo D, et al
    Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 30. pii: ijgc-2020-001710.
    PubMed     Abstract available


  33. SMALL W JR, Peltecu G, Puiu A, Corha A, et al
    Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference.
    Int J Gynecol Cancer. 2020 Oct 29. pii: ijgc-2020-001652.
    PubMed     Abstract available


  34. PRECI DP, Almeida A, Weiler AL, Mukai Franciosi ML, et al
    Oxidative damage and antioxidants in cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 27. pii: ijgc-2020-001587.
    PubMed     Abstract available


  35. ALLANSON ER, Velanova V, Frazer IH, McAdam M, et al
    An update on cervical cancer screening in Vanuatu.
    Int J Gynecol Cancer. 2020 Oct 26. pii: ijgc-2020-002129.
    PubMed    


  36. LIN F, Zheng R, Yu C, Su Y, et al
    Predictive role of serum cholesterol and triglycerides in cervical cancer survival.
    Int J Gynecol Cancer. 2020 Oct 13. pii: ijgc-2020-001333.
    PubMed     Abstract available


  37. BERCOW AS, Nitecki R, Haber H, Gockley AA, et al
    Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 12. pii: ijgc-2020-001812.
    PubMed     Abstract available


  38. NICA A, Kim SR, Gien LT, Covens A, et al
    Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?
    Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001816.
    PubMed     Abstract available


  39. ANDERSEN B, Njor SH, Jensen AMS, Johansen T, et al
    HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study.
    Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001457.
    PubMed     Abstract available


  40. HARRISON R, Ramirez PT
    Bronchocutaneous fistula from metastatic cervical cancer with COVID-19.
    Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001976.
    PubMed    


  41. DE CUYPERE M, Lovinfosse P, Gennigens C, Hermesse J, et al
    Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 8. pii: ijgc-2020-001676.
    PubMed     Abstract available


    September 2020
  42. GOVOROV I, Dikareva E, Velichko E, Kesic V, et al
    Human-machine alliance against cervical cancer.
    Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-002064.
    PubMed    


  43. GULTEKIN M, Beduk Esen CS, Balci B, Alanyali S, et al
    Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).
    Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-001733.
    PubMed     Abstract available


  44. NAGASE Y, Kobayashi E, Takiuchi T, Kodama M, et al
    Challenges of laparoscopic lymphadenectomy for cervical cancer in pregnant women: techniques and tips.
    Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-001703.
    PubMed    


  45. TU H, Huang H, Xian B, Li J, et al
    Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010).
    Int J Gynecol Cancer. 2020 Sep 24. pii: ijgc-2020-001857.
    PubMed     Abstract available


  46. SALVO G, Odetto D, Saenz Perrotta C, Noll F, et al
    Tumor size in cervical cancer: an ongoing dilemma.
    Int J Gynecol Cancer. 2020 Sep 21. pii: ijgc-2020-002022.
    PubMed    


  47. RAHMAN MS, Gultekin M, Lassi ZS
    Effective approaches towards eliminating cervical cancer from low-and middle-income countries amid COVID-19 pandemic.
    Int J Gynecol Cancer. 2020 Sep 14. pii: ijgc-2020-002013.
    PubMed    


  48. LI R, Germino E, Horne ZD, Vargo JA, et al
    External beam radiation and brachytherapy boost at different facilities is associated with increased treatment delays in cervical cancer.
    Int J Gynecol Cancer. 2020 Sep 14. pii: ijgc-2020-001700.
    PubMed     Abstract available


  49. KHULPATEEA BR, Paulson A, Carlson M, Miller DS, et al
    Stage IVA cervical cancer: outcomes of disease related complications and treatment.
    Int J Gynecol Cancer. 2020 Sep 12. pii: ijgc-2019-000386.
    PubMed     Abstract available


  50. PERROTTA M, Noll F, Cortez JPS, Bolano L, et al
    Simple trachelectomy with laparoscopic pelvic lymphadenectomy in a pregnant woman with a FIGO stage IA2 cervical cancer.
    Int J Gynecol Cancer. 2020 Sep 6. pii: ijgc-2020-001603.
    PubMed    


    August 2020
  51. BONA AF, Ferreira KR, Carvalho RBM, Thuler LCS, et al
    Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2020 Aug 30. pii: ijgc-2020-001682.
    PubMed     Abstract available


  52. NITECKI R, Melamed A
    Time to accept a new old standard of care in cervical cancer.
    Int J Gynecol Cancer. 2020 Aug 12. pii: ijgc-2020-001870.
    PubMed    


  53. JYANI G, Chauhan AS, Rai B, Ghoshal S, et al
    Health-related quality of life among cervical cancer patients in India.
    Int J Gynecol Cancer. 2020 Aug 11. pii: ijgc-2020-001455.
    PubMed     Abstract available


  54. MARTINEZ A, Angeles MA, Querleu D, Ferron G, et al
    How should we stage and tailor treatment strategy in locally advanced cervical cancer? Imaging versus para-aortic surgical staging.
    Int J Gynecol Cancer. 2020 Aug 11. pii: ijgc-2020-001351.
    PubMed     Abstract available


  55. CHIVA L, Zanagnolo V, Querleu D, Martin-Calvo N, et al
    SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer.
    Int J Gynecol Cancer. 2020 Aug 11. pii: ijgc-2020-001506.
    PubMed     Abstract available


  56. ODETTO D, Perrotta M, Saadi JM, Chacon CB, et al
    Infection versus cancer: management of actinomyces mimicking cervical cancer or ovarian cancer.
    Int J Gynecol Cancer. 2020 Aug 4. pii: ijgc-2020-001800.
    PubMed    


  57. BALAYA V, Bresset A, Guani B, Benoit L, et al
    Pre-operative surgical algorithm: sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer.
    Int J Gynecol Cancer. 2020 Aug 4. pii: ijgc-2020-001586.
    PubMed     Abstract available


  58. MATSUO K, Matsuzaki S, Mandelbaum RS, Klar M, et al
    Financial viewpoint of minimally invasive radical hysterectomy for early cervical cancer: another disadvantage?
    Int J Gynecol Cancer. 2020 Aug 2. pii: ijgc-2020-001794.
    PubMed    



  59. Correction: Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.
    Int J Gynecol Cancer. 2020;30:1267.
    PubMed    



  60. Correction: Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer.
    Int J Gynecol Cancer. 2020;30:1266.
    PubMed    


  61. CIAVATTINI A, Delli Carpini G, Giannella L, Arbyn M, et al
    European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic.
    Int J Gynecol Cancer. 2020;30:1097-1100.
    PubMed    


    July 2020
  62. SALCEDO MP, Oliveira C, Andrade V, Mariano AAN, et al
    The Capulana study: a prospective evaluation of cervical cancer screening using human papillomavirus testing in Mozambique.
    Int J Gynecol Cancer. 2020 Jul 30. pii: ijgc-2020-001643.
    PubMed     Abstract available


  63. HE J, Hao M, Liu P, Liu Z, et al
    Comparison of laparoscopic and abdominal radical hysterectomy for early stage cervical cancer: oncologic outcomes based on tumor diameter.
    Int J Gynecol Cancer. 2020 Jul 22. pii: ijgc-2020-001504.
    PubMed     Abstract available


  64. MADARIAGA A, Kasherman L, Han K, Lheureux S, et al
    Adjuvant treatment in early stage cervical cancer-does more equal better?
    Int J Gynecol Cancer. 2020 Jul 20. pii: ijgc-2020-001840.
    PubMed    


  65. AMRIT A, Mani K
    Technology in the prevention of cervical cancer.
    Int J Gynecol Cancer. 2020 Jul 20. pii: ijgc-2020-001826.
    PubMed    


  66. BAIOCCHI JMT, Baiocchi G, Bergmann A
    Is there a place for lower limb lymphedema prevention after cervical cancer treatment?
    Int J Gynecol Cancer. 2020 Jul 16. pii: ijgc-2020-001532.
    PubMed    


  67. DING Y, Wang X, Cai H
    Reply to: Is there a place for lower limb lymphedema prevention after cervical cancer treatment?
    Int J Gynecol Cancer. 2020 Jul 16. pii: ijgc-2020-001648.
    PubMed    


  68. SIMS TT, Biegert GWG, Ramogola-Masire D, Ngoni K, et al
    Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer.
    Int J Gynecol Cancer. 2020 Jul 16. pii: ijgc-2020-001547.
    PubMed     Abstract available


  69. DALWADI S, Echeverria A, Jhaveri P, Bui T, et al
    Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2020 Jul 6. pii: ijgc-2019-001104.
    PubMed     Abstract available


  70. SALVO G, Odetto D, Saez Perrotta MC, Noll F, et al
    Measurement of tumor size in early cervical cancer: an ever-evolving paradigm.
    Int J Gynecol Cancer. 2020 Jul 6. pii: ijgc-2020-001436.
    PubMed     Abstract available


  71. LIU H, Meng X, Wang J
    Real time quantitative methylation detection of PAX1 gene in cervical cancer screening.
    Int J Gynecol Cancer. 2020 Jul 2. pii: ijgc-2019-001144.
    PubMed     Abstract available



  72. Correction: Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer.
    Int J Gynecol Cancer. 2020;30:1087.
    PubMed    


    June 2020
  73. GOGINENI E, Bloom B, Diaz Molina F, Villella J, et al
    Radiotherapy dose escalation on pelvic lymph node control in patients with cervical cancer.
    Int J Gynecol Cancer. 2020 Jun 30. pii: ijgc-2020-001342.
    PubMed     Abstract available


  74. VAN DEN AKKER MJE, Horeweg N, Beltman JJ, Creutzberg CL, et al
    Efficacy and toxicity of postoperative external beam radiotherapy or chemoradiation for early-stage cervical cancer.
    Int J Gynecol Cancer. 2020 Jun 25. pii: ijgc-2019-001131.
    PubMed     Abstract available


  75. HU TWY, Huang Y, Li N, Nie D, et al
    Comparison of laparoscopic versus open radical hysterectomy in patients with early-stage cervical cancer: a multicenter study in China.
    Int J Gynecol Cancer. 2020 Jun 22. pii: ijgc-2020-001340.
    PubMed     Abstract available


  76. WEYL A, Illac C, Lusque A, Leray H, et al
    Prognostic value of lymphovascular space invasion in early-stage cervical cancer.
    Int J Gynecol Cancer. 2020 Jun 21. pii: ijgc-2020-001274.
    PubMed     Abstract available


  77. SILVA JS, Leite PD
    Challenges in cervical cancer in the Amazon (Brazil).
    Int J Gynecol Cancer. 2020 Jun 18. pii: ijgc-2020-001474.
    PubMed    


  78. KIM YJ, Kim YS, Shin JW, Osong B, et al
    Prediction scoring system based on clinicohematologic parameters for cervical cancer patients undergoing chemoradiation.
    Int J Gynecol Cancer. 2020 Jun 16. pii: ijgc-2019-001050.
    PubMed     Abstract available


  79. CONTRERAS J, Srivastava A, Chundury A, Schwarz JK, et al
    Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
    Int J Gynecol Cancer. 2020 Jun 11. pii: ijgc-2020-001412.
    PubMed     Abstract available


  80. SAKURAGI N, Kaneuchi M, Kato T, Shimada C, et al
    Tailored radical hysterectomy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2020 Jun 9. pii: ijgc-2020-001387.
    PubMed     Abstract available


  81. TU H, Huang H, Ouyang Y, Liu Q, et al
    Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer: the CSEM 006 study.
    Int J Gynecol Cancer. 2020 Jun 9. pii: ijgc-2020-001357.
    PubMed     Abstract available


  82. ZHANG L, Zhang H, Huang Y, Xi X, et al
    Expression of immune cell markers and tumor markers in patients with cervical cancer.
    Int J Gynecol Cancer. 2020 Jun 8. pii: ijgc-2020-001254.
    PubMed     Abstract available


  83. PLANTE M, Renaud MC, Sebastianelli A, Gregoire J, et al
    Simple vaginal trachelectomy in women with early-stage low-risk cervical cancer who wish to preserve fertility: the new standard of care?
    Int J Gynecol Cancer. 2020 Jun 3. pii: ijgc-2020-001432.
    PubMed     Abstract available


  84. PEDRA NOBRE S, Mazina V, Iasonos A, Zhou QC, et al
    Surveillance patterns of cervical cancer patients treated with conization alone.
    Int J Gynecol Cancer. 2020 Jun 3. pii: ijgc-2020-001338.
    PubMed     Abstract available


    May 2020
  85. YUAN Y, You J, Li X, Wang W, et al
    Adjuvant chemotherapy after radiotherapy or concurrent chemoradiotherapy for pelvic lymph node-positive patients with locally advanced cervical cancer: a propensity score matching analysis.
    Int J Gynecol Cancer. 2020 May 30. pii: ijgc-2020-001230.
    PubMed     Abstract available


  86. HWANG WY, Kim JH, Suh DH, Kim K, et al
    The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Int J Gynecol Cancer. 2020 May 28. pii: ijgc-2020-001271.
    PubMed     Abstract available


  87. BOGANI G, Ghezzi F, Chiva L, Gisone B, et al
    Patterns of recurrence after laparoscopic versus open abdominal radical hysterectomy in patients with cervical cancer: a propensity-matched analysis.
    Int J Gynecol Cancer. 2020 May 23. pii: ijgc-2020-001381.
    PubMed     Abstract available


  88. MAYADEV J, Nunes AT, Li M, Marcovitz M, et al
    CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.
    Int J Gynecol Cancer. 2020 May 23. pii: ijgc-2019-001135.
    PubMed     Abstract available


  89. MARQUES RM, Tsunoda AT, Dias RS, Pimenta JM, et al
    Robotic uterine transposition for a cervical cancer patient with pelvic micrometastases after conization and pelvic lymphadenectomy.
    Int J Gynecol Cancer. 2020 May 18. pii: ijgc-2020-001250.
    PubMed    


  90. TSAKMAKLIS A, Vehreschild M, Farowski F, Trommer M, et al
    Changes in the cervical microbiota of cervical cancer patients after primary radio-chemotherapy.
    Int J Gynecol Cancer. 2020 May 5. pii: ijgc-2019-000801.
    PubMed     Abstract available



  91. Correction: Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer.
    Int J Gynecol Cancer. 2020 May 4. pii: ijgc-2019-001012.
    PubMed    


  92. GROHAR D, Vassilakos P, Benkortbi K, Tincho E, et al
    Scaling up community-based cervical cancer screening in Cameroon employing a single visit approach.
    Int J Gynecol Cancer. 2020 May 4. pii: ijgc-2020-001422.
    PubMed    


  93. VAZQUEZ-VICENTE D, Castellanos T, Cabello A, Chacon E, et al
    Multidisciplinary approach in the pelvic relapse of a previously irradiated cervical tumor.
    Int J Gynecol Cancer. 2020;30:714.
    PubMed    


  94. GULTEKIN M, Turan SH, Boztas G, Ozturk C, et al
    Passion for saving lives: Turkey between 2012 and 2017.
    Int J Gynecol Cancer. 2020;30:709-710.
    PubMed    


  95. PAREJA R
    Safety of minimally invasive radical hysterectomy in cervical tumors <2 cm.
    Int J Gynecol Cancer. 2020;30:572-574.
    PubMed    


    April 2020
  96. NUNES DE ARRUDA F, da Costa S, Bonadio R, Dornellas A, et al
    Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.
    Int J Gynecol Cancer. 2020 Apr 21. pii: ijgc-2019-001134.
    PubMed     Abstract available


  97. CHEN X, Zhao N, Ye P, Chen J, et al
    Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size </=2 cm.
    Int J Gynecol Cancer. 2020 Apr 9. pii: ijgc-2019-000994.
    PubMed     Abstract available


  98. YOUN SH, Kim YJ, Seo SS, Kang S, et al
    Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea.
    Int J Gynecol Cancer. 2020 Apr 9. pii: ijgc-2020-001200.
    PubMed     Abstract available


  99. DOSTALEK L, Slama J, Fisherova D, Kocian R, et al
    Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer.
    Int J Gynecol Cancer. 2020 Apr 9. pii: ijgc-2019-001113.
    PubMed     Abstract available


  100. SALVO G, Odetto D, Pareja R, Frumovitz M, et al
    Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain.
    Int J Gynecol Cancer. 2020 Apr 1. pii: ijgc-2020-001257.
    PubMed     Abstract available


  101. CHAMBERS LM, Herrmann A, Michener CM, Ferrando CA, et al
    Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma.
    Int J Gynecol Cancer. 2020;30:515-524.
    PubMed     Abstract available


    March 2020
  102. TREJO MJ, Lishimpi K, Kalima M, Mwaba CK, et al
    Effects of HIV status on non-metastatic cervical cancer progression among patients in Lusaka, Zambia.
    Int J Gynecol Cancer. 2020 Mar 21. pii: ijgc-2019-000987.
    PubMed     Abstract available


  103. MORO F, Gui B, Arciuolo D, Bertoldo V, et al
    Fusion imaging of ultrasound and MRI in the assessment of locally advanced cervical cancer: a prospective study.
    Int J Gynecol Cancer. 2020 Mar 18. pii: ijgc-2019-000902.
    PubMed     Abstract available


  104. LAZZARI R, Riva G, Augugliaro M, Vavassori A, et al
    Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
    Int J Gynecol Cancer. 2020 Mar 17. pii: ijgc-2019-000735.
    PubMed     Abstract available


  105. MARGOLIS B, Cagle-Colon K, Chen L, Tergas AI, et al
    Prognostic significance of lymphovascular space invasion for stage IA1 and IA2 cervical cancer.
    Int J Gynecol Cancer. 2020 Mar 15. pii: ijgc-2019-000849.
    PubMed     Abstract available


  106. MUROFUSHI K, Yoshioka Y, Sumi M, Ishikawa H, et al
    Outcomes analysis of pre-brachytherapy MRI in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2020 Mar 11. pii: ijgc-2019-000925.
    PubMed     Abstract available


  107. ZHONG ML, Wang YN, Liang MR, Liu H, et al
    Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy.
    Int J Gynecol Cancer. 2020 Mar 9. pii: ijgc-2019-000690.
    PubMed     Abstract available


  108. ALLDREDGE J, Leaf MC, Patel P, Coakley K, et al
    Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort study.
    Int J Gynecol Cancer. 2020 Mar 9. pii: ijgc-2019-000909.
    PubMed     Abstract available


  109. GULTEKIN M, Ramirez PT, Broutet N, Hutubessy R, et al
    World Health Organization call for action to eliminate cervical cancer globally.
    Int J Gynecol Cancer. 2020 Mar 2. pii: ijgc-2020-001285.
    PubMed    


  110. GULTEKIN M, Morice P, Concin N, Querleu D, et al
    ESGO contribution to the WHO initiative on elimination of cervical cancer.
    Int J Gynecol Cancer. 2020 Mar 2. pii: ijgc-2020-001286.
    PubMed    


    February 2020
  111. CHASE D, Huang HQ, Monk BJ, Ramondetta LM, et al
    Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.
    Int J Gynecol Cancer. 2020 Feb 28. pii: ijgc-2019-000869.
    PubMed     Abstract available


  112. WANG X, Ding Y, Cai HY, You J, et al
    Effectiveness of modified complex decongestive physiotherapy for preventing lower extremity lymphedema after radical surgery for cervical cancer: a randomized controlled trial.
    Int J Gynecol Cancer. 2020 Feb 26. pii: ijgc-2019-000911.
    PubMed     Abstract available


  113. LOVERIX L, Salihi RR, Van Nieuwenhuysen E, Concin N, et al
    Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy.
    Int J Gynecol Cancer. 2020 Feb 19. pii: ijgc-2019-000961.
    PubMed     Abstract available


  114. RAMIREZ PT, Pareja R, Eriksson AGZ, Frumovitz M, et al
    International Gynecologic Cancer Society 2019 meeting summary.
    Int J Gynecol Cancer. 2020;30:167-173.
    PubMed    


  115. LEITAO MM JR
    The aftershocks of the LACC earthquake have begun: brace yourselves.
    Int J Gynecol Cancer. 2020;30:157-159.
    PubMed    


  116. GOROSTIDI M, Lekuona A, Juaristi A, Baiocchi G, et al
    Vaginal carcinoma after cervical dysplasia.
    Int J Gynecol Cancer. 2020;30:265-273.
    PubMed    


  117. LI J, Ouyang Y, Tao Y, Wang L, et al
    Small cell carcinoma of the uterine cervix: a multi-institutional experience.
    Int J Gynecol Cancer. 2020;30:174-180.
    PubMed     Abstract available


  118. SEKIYAMA K, Ando Y, Taga A, Kozono Y, et al
    Laparoscopic technique for step-by-step nerve-sparing Okabayashi radical hysterectomy.
    Int J Gynecol Cancer. 2020;30:276-277.
    PubMed    


    January 2020
  119. BIZZARRI N, Pedone Anchora L, Zannoni GF, Santoro A, et al
    Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
    Int J Gynecol Cancer. 2020 Jan 23. pii: ijgc-2019-000939.
    PubMed     Abstract available


  120. RYCHLIK A, Angeles MA, Migliorelli F, Croce S, et al
    Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer.
    Int J Gynecol Cancer. 2020 Jan 6. pii: ijgc-2019-000904.
    PubMed     Abstract available


  121. CIBULA D, Planchamp F, Fischerova D, Fotopoulou C, et al
    European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer.
    Int J Gynecol Cancer. 2020;30:3-14.
    PubMed     Abstract available


  122. RAMIREZ PT
    Quality indicators in cervical cancer surgery: a valiant step in the right direction.
    Int J Gynecol Cancer. 2020;30:1-2.
    PubMed    


  123. QUERLEU D, Cibula D, Concin N, Fagotti A, et al
    Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement.
    Int J Gynecol Cancer. 2020;30:15.
    PubMed    


  124. ALAN M, Gunyeli I, Gultekin M, Sanci M, et al
    Correlation of Swede score colposcopy scoring system and histopathological results in patients with high-risk HPV infection other than HPV16 and 18.
    Int J Gynecol Cancer. 2020;30:35-40.
    PubMed     Abstract available


  125. RICCIARDI E, Plett H, Sangiorgio V, Paderno M, et al
    Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series.
    Int J Gynecol Cancer. 2020;30:21-28.
    PubMed     Abstract available


  126. ORTIZ MOLINA E, Diaz de la Noval B, Rodriguez Suarez MJ, Hernandez Pailos R, et al
    Maylard's incision: how to make an easy incision for complex pelvic abdominal surgery.
    Int J Gynecol Cancer. 2020;30:154-155.
    PubMed    


  127. MARTINEZ-GOMEZ C, Angeles MA, Migliorelli F, Martinez A, et al
    Creation of a Y-shaped ileal orthotopic neobladder after an anterior pelvic exenteration in 10 logical steps.
    Int J Gynecol Cancer. 2020;30:152-153.
    PubMed    


  128. GRAU JF, Farinas-Madrid L, Oaknin A
    A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATc
    Int J Gynecol Cancer. 2020;30:139-143.
    PubMed     Abstract available


    December 2019
  129. MAYADEV J, Zamarin D, Deng W, Lankes H, et al
    Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Dec 22. pii: ijgc-2019-001012.
    PubMed     Abstract available


  130. NICA A, Gien LT, Ferguson SE, Covens A, et al
    Does small volume metastatic lymph node disease affect long-term prognosis in early cervical cancer?
    Int J Gynecol Cancer. 2019 Dec 22. pii: ijgc-2019-000928.
    PubMed     Abstract available


  131. BATAILLE B, Escande A, Le Tinier F, Parent A, et al
    Outcomes of pre-operative brachytherapy followed by hysterectomy for early cervical cancer.
    Int J Gynecol Cancer. 2019 Dec 22. pii: ijgc-2019-000617.
    PubMed     Abstract available


  132. ESTRADA EE
    Sentinel lymph node detection in patients with cervical cancer in a public hospital in Guatemala.
    Int J Gynecol Cancer. 2019 Dec 8. pii: ijgc-2019-000839.
    PubMed    


    November 2019
  133. BERNARD L, Fearon D, McFaul S, Faught W, et al
    Role of primary care enrolment in advanced cervical cancer diagnosis: a population-based case-control study.
    Int J Gynecol Cancer. 2019 Nov 27. pii: ijgc-2019-000713.
    PubMed     Abstract available


  134. DOSTALEK L, Runnebaum I, Raspagliesi F, Vergote I, et al
    Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer).
    Int J Gynecol Cancer. 2019 Nov 20. pii: ijgc-2019-000890.
    PubMed     Abstract available


  135. TESFAI FM, Kroep JR, Gaarenstroom K, De Kroon C, et al
    Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.
    Int J Gynecol Cancer. 2019 Nov 19. pii: ijgc-2019-000647.
    PubMed     Abstract available


    October 2019
  136. SOZZI G, Berretta R, Fiengo S, Ferreri M, et al
    Integrated pre-surgical diagnostic algorithm to define extent of disease in cervical cancer.
    Int J Gynecol Cancer. 2019 Oct 23. pii: ijgc-2019-000665.
    PubMed     Abstract available


    September 2019
  137. CHO WK, Kim YI, Park W, Yang K, et al
    Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer.
    Int J Gynecol Cancer. 2019;29:1116-1120.
    PubMed     Abstract available


  138. MELNIKOFF AK, Doo DW, Cohen AC, Landers E, et al
    Timing of robotic hysterectomy after cervical excisional procedure.
    Int J Gynecol Cancer. 2019;29:1110-1115.
    PubMed     Abstract available


    August 2019
  139. FOKOM DOMGUE J, Manjuh F, Nulah K, Welty T, et al
    Onsite training of clinicians on new techniques to improve cervical cancer prevention in sub-Saharan Africa.
    Int J Gynecol Cancer. 2019 Aug 30. pii: ijgc-2019-000772.
    PubMed    


  140. LIN AJ, Wright JD, Dehdashti F, Siegel BA, et al
    Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with (18)F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer.
    Int J Gynecol Cancer. 2019 Aug 30. pii: ijgc-2019-000528.
    PubMed     Abstract available


  141. MCKENZIE ND, Ahmad S, Bernard J Jr, DeGennaro V Jr, et al
    Empowering and training front-line providers treating cervical cancer in Haiti: perspective of a gynecologic oncologist's experience with international surgical missions.
    Int J Gynecol Cancer. 2019 Aug 26. pii: ijgc-2019-000758.
    PubMed    


  142. BOGANI G, Vinti D, Murgia F, Chiappa V, et al
    Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
    Int J Gynecol Cancer. 2019 Aug 17. pii: ijgc-2019-000669.
    PubMed     Abstract available


  143. CAO L, Wen H, Feng Z, Han X, et al
    Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer.
    Int J Gynecol Cancer. 2019 Aug 17. pii: ijgc-2019-000556.
    PubMed     Abstract available


  144. WARD K, Ramzan A, Sheeder J, Fischer S, et al
    Persistent opioid use after radiation therapy in opioid-naive cervical cancer survivors.
    Int J Gynecol Cancer. 2019 Aug 15. pii: ijgc-2019-000430.
    PubMed     Abstract available


  145. SIMONDS H, Botha MH, Ellmann A, Warwick J, et al
    HIV status does not have an impact on positron emission tomography-computed tomography (PET-CT) findings or radiotherapy treatment recommendations in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Aug 13. pii: ijgc-2019-000641.
    PubMed     Abstract available


    July 2019
  146. QUERLEU D, Leblanc E
    Combined vaginal and laparoscopic approach for the surgical management of cervical cancer: a historic note.
    Int J Gynecol Cancer. 2019 Jul 27. pii: ijgc-2019-000750.
    PubMed    


  147. COLA E, Maziku D, Torelli GF, Fagotti A, et al
    Cervical cancer in Tosamaganga Hospital, Tanzania: difficulties and challenges in a low resource country setting.
    Int J Gynecol Cancer. 2019 Jul 19. pii: ijgc-2019-000505.
    PubMed    


  148. SALVO G, Gonzalez Martin A, Gonzales NR, Frumovitz M, et al
    Updates and management algorithm for neuroendocrine tumors of the uterine cervix.
    Int J Gynecol Cancer. 2019;29:986-995.
    PubMed     Abstract available


  149. ILIC I, Babic G, Dimitrijevic A, Ilic M, et al
    Reliability and validity of the Center for Epidemiologic Studies Depression (CES-D) scale in Serbian women with abnormal Papanicolaou smear results.
    Int J Gynecol Cancer. 2019;29:996-1002.
    PubMed     Abstract available


  150. KOENEMAN MM, Hendriks N, Kooreman LF, Winkens B, et al
    Prognostic factors for spontaneous regression of high-risk human papillomavirus-positive cervical intra-epithelial neoplasia grade 2.
    Int J Gynecol Cancer. 2019;29:1003-1009.
    PubMed     Abstract available


  151. CHUANG LT
    Ten years of collaboration in Honduras.
    Int J Gynecol Cancer. 2019;29:1082.
    PubMed    


    June 2019
  152. FALCONER H, Palsdottir K, Stalberg K, Dahm-Kahler P, et al
    Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial.
    Int J Gynecol Cancer. 2019 Jun 14. pii: ijgc-2019-000558.
    PubMed     Abstract available


  153. UPPAL S, Spencer R
    Modify or abandon: minimally invasive radical hysterectomy for early-stage cervical cancer.
    Int J Gynecol Cancer. 2019;29:843-844.
    PubMed    


  154. ODETTO D, Puga MC, Saadi J, Noll F, et al
    Minimally invasive radical hysterectomy: an analysis of oncologic outcomes from Hospital Italiano (Argentina).
    Int J Gynecol Cancer. 2019;29:863-868.
    PubMed     Abstract available


  155. KOHLER C, Hertel H, Herrmann J, Marnitz S, et al
    Laparoscopic radical hysterectomy with transvaginal closure of vaginal cuff - a multicenter analysis.
    Int J Gynecol Cancer. 2019;29:845-850.
    PubMed     Abstract available


    May 2019
  156. VAN DER VELDEN J, Mom CH, van Lonkhuijzen L, Tjiong MY, et al
    Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy.
    Int J Gynecol Cancer. 2019 May 27. pii: ijgc-2019-000445.
    PubMed     Abstract available


  157. PLANTE M, van Trommel N, Lheureux S, Oza AM, et al
    FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG,
    Int J Gynecol Cancer. 2019 May 17. pii: ijgc-2019-000398.
    PubMed     Abstract available


  158. ZHANG W, Chen C, Liu P, Li W, et al
    Staging early cervical cancer in China: data from a multicenter collaborative.
    Int J Gynecol Cancer. 2019 May 15. pii: ijgc-2019-000263.
    PubMed     Abstract available


    April 2019
  159. BAINS I, Choi YH, Soldan K, Jit M, et al
    Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England.
    Int J Gynecol Cancer. 2019 Apr 24. pii: ijgc-2018-000161.
    PubMed     Abstract available


  160. SALCEDO MP, Lorenzoni C, Schmeler KM
    Working together to eliminate cervical cancer: a partnership across three countries "As mudancas no mundo sao criadas por nos".
    Int J Gynecol Cancer. 2019 Apr 3. pii: ijgc-2019-000372.
    PubMed    


    March 2019
  161. LECURU FR, McCormack M, Hillemanns P, Anota A, et al
    SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study.
    Int J Gynecol Cancer. 2019 Mar 20. pii: ijgc-2019-000332.
    PubMed     Abstract available


  162. HALASKA MJ, Uzan C, Han SN, Fruscio R, et al
    Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy.
    Int J Gynecol Cancer. 2019 Mar 20. pii: ijgc-2018-000103.
    PubMed     Abstract available


  163. RAZ Y, Keinan-Boker L, Goren S, Soen-Grisaru G, et al
    The effect of age at immigration on cervical cancer incidence: a population-based cohort study of 1 486 438 Israeli women.
    Int J Gynecol Cancer. 2019;29:492-496.
    PubMed     Abstract available


  164. MABUCHI S, Yokoi E, Shimura K, Komura N, et al
    A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy.
    Int J Gynecol Cancer. 2019;29:474-479.
    PubMed     Abstract available


  165. GUANI B, Dorez M, Magaud L, Buenerd A, et al
    Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial.
    Int J Gynecol Cancer. 2019;29:447-452.
    PubMed     Abstract available


    February 2019
  166. YANG L, Chen H
    Establishing the prognostic value of platelet-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2019 Feb 9. pii: ijgc-2018-000090.
    PubMed     Abstract available


  167. HUANG Y, He Q, Xu K, Zhou J, et al
    A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Feb 7. pii: ijgc-2018-000095.
    PubMed     Abstract available


  168. ANGELES MA, Baissas P, Leblanc E, Lusque A, et al
    Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
    Int J Gynecol Cancer. 2019 Feb 1. pii: ijgc-2018-000168.
    PubMed     Abstract available


    January 2019
  169. RAMIREZ PT, Abu-Rustum NR, Euscher E
    Conservative management of cervical cancer in pregnancy.
    Int J Gynecol Cancer. 2019 Jan 23. pii: ijgc-2018-000187.
    PubMed    


  170. RAJASOORIYAR C, Lin MY, Kalra R, Lim A, et al
    The role of positron emission tomography in the selection of patients for salvage hysterectomy following chemoradiotherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Jan 10. pii: ijgc-2018-000088.
    PubMed     Abstract available


  171. HATA M
    Radiation therapy for elderly patients with uterine cervical cancer: feasibility of curative treatment.
    Int J Gynecol Cancer. 2019 Jan 10. pii: ijgc-2018-000077.
    PubMed     Abstract available


  172. HOREWEG N, Creutzberg CL, Rijkmans EC, Laman MS, et al
    Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Jan 10. pii: ijgc-2018-000057.
    PubMed     Abstract available


  173. CIBULA D, Dusek J, Jarkovsky J, Dundr P, et al
    A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX).
    Int J Gynecol Cancer. 2019;29:212-215.
    PubMed     Abstract available


  174. CORDERO-GALLARDO F, Lee Burnett O 3rd, McNamara MM, Weber TM, et al
    Incidence of mesorectal node metastasis in locally advanced cervical cancer: its therapeutic implications.
    Int J Gynecol Cancer. 2019;29:48-52.
    PubMed     Abstract available


  175. YAVAS G, Yavas C, Sen E, Oner I, et al
    Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019;29:42-47.
    PubMed     Abstract available


  176. NEWMAN H, Hu J, Li X, He J, et al
    Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
    Int J Gynecol Cancer. 2019;29:23-27.
    PubMed     Abstract available


  177. YOSHINO Y, Taguchi A, Shimizuguchi T, Nakajima Y, et al
    A low albumin to globulin ratio with a high serum globulin level is a prognostic marker for poor survival in cervical cancer patients treated with radiation based therapy.
    Int J Gynecol Cancer. 2019;29:17-22.
    PubMed     Abstract available


  178. CHONG GO, Han HS, Park JY, Lee SD, et al
    Prevalence, survival outcomes, and clinicopathologic factors associated with negative high risk human papillomavirus in surgical specimens of cervical cancer with pretreatment negative DNA genotype test.
    Int J Gynecol Cancer. 2019;29:10-16.
    PubMed     Abstract available


    November 2018
  179. RODOLAKIS A, Thomakos N, Sotiropoulou M, Kypriotis K, et al
    Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer During Pregnancy: A Provocative Surgical Approach. Overview of the Literature and a Single-Institute Experience.
    Int J Gynecol Cancer. 2018;28:1743-1750.
    PubMed     Abstract available


    October 2018
  180. TINKER AV, Fiorino L, O'Dwyer H, Kumar A, et al
    Bevacizumab in Metastatic, Recurrent, or Persistent Cervical Cancer: The BC Cancer Experience.
    Int J Gynecol Cancer. 2018;28:1592-1599.
    PubMed     Abstract available


  181. AMINI A, Robin TP, Stumpf PK, Rusthoven C, et al
    Rising Rates of Upfront Surgery in Early Locally Advanced Cervical Cancer: What Factors Predict for This Treatment Paradigm?
    Int J Gynecol Cancer. 2018;28:1560-1568.
    PubMed     Abstract available


    August 2018
  182. FAGOTTI A, Conte C, Stollagli F, Gallotta V, et al
    Radical Surgery in Advanced Cervical Cancer Patients Receiving Bevacizumab-Containing Chemotherapy: A "Real Life Experience".
    Int J Gynecol Cancer. 2018 Aug 29. doi: 10.1097/IGC.0000000000001350.
    PubMed     Abstract available


  183. WANG W, Liu X, Meng Q, Zhang F, et al
    Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis.
    Int J Gynecol Cancer. 2018 Aug 27. doi: 10.1097/IGC.0000000000001344.
    PubMed     Abstract available


  184. HE F, Du J, Chen X, He L, et al
    Assessment of Parametrial Involvement in Early Stages Cervical Cancer With Preoperative Magnetic Resonance Imaging.
    Int J Gynecol Cancer. 2018 Aug 27. doi: 10.1097/IGC.0000000000001349.
    PubMed     Abstract available


  185. LEITAO MM JR
    The LACC Trial: Has Minimally Invasive Surgery for Early-Stage Cervical Cancer Been Dealt a Knockout Punch? An Invited Editorial.
    Int J Gynecol Cancer. 2018 Aug 7. doi: 10.1097/IGC.0000000000001342.
    PubMed    


  186. ZHANG L, He Q, Jiang M, Zhang B, et al
    Diagnosis of Insufficiency Fracture After Radiotherapy in Patients With Cervical Cancer: Contribution of Technetium Tc 99m-Labeled Methylene Diphosphonate Single-Photon Emission Computed Tomography/Computed Tomography.
    Int J Gynecol Cancer. 2018 Aug 7. doi: 10.1097/IGC.0000000000001337.
    PubMed     Abstract available


  187. TOMITA N, Mizuno M, Makita C, Kondo S, et al
    Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
    Int J Gynecol Cancer. 2018 Aug 7. doi: 10.1097/IGC.0000000000001336.
    PubMed     Abstract available


  188. YOU KY, Zhou XH, Jiang YH, Bi ZF, et al
    The Selection of Time Interval Between Surgery and Adjuvant Therapy in Early Stage Cervical Cancer.
    Int J Gynecol Cancer. 2018 Aug 1. doi: 10.1097/IGC.0000000000001307.
    PubMed     Abstract available


    July 2018
  189. CHEN XL, Chen GW, Xu GH, Ren J, et al
    Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.
    Int J Gynecol Cancer. 2018 Jul 23. doi: 10.1097/IGC.0000000000001327.
    PubMed     Abstract available


  190. TSENG JH, Aloisi A, Sonoda Y, Gardner GJ, et al
    Long-Term Oncologic Outcomes of Uterine-Preserving Surgery in Young Women With Stage Ib1 Cervical Cancer.
    Int J Gynecol Cancer. 2018 Jul 20. doi: 10.1097/IGC.0000000000001319.
    PubMed     Abstract available


  191. RUBINSAK LA, Kang L, Fields EC, Carter JS, et al
    Treatment-Related Radiation Toxicity Among Cervical Cancer Patients.
    Int J Gynecol Cancer. 2018 Jul 20. doi: 10.1097/IGC.0000000000001309.
    PubMed     Abstract available


  192. HUANG K, Jia M, Li P, Han J, et al
    Radiotherapy Improves the Survival of Patients With Metastatic Cervical Cancer: A Propensity-Matched Analysis of SEER Database.
    Int J Gynecol Cancer. 2018 Jul 20. doi: 10.1097/IGC.0000000000001313.
    PubMed     Abstract available


  193. SNYMAN LC, Bryant EP, Wethmar EI, de Greve T, et al
    Use of a Sentinel Lymph Node Biopsy Algorithm in a South African Population of Patients With Cervical Cancer and High Prevalence of Human Immunodeficiency Virus Infection.
    Int J Gynecol Cancer. 2018 Jul 20. doi: 10.1097/IGC.0000000000001310.
    PubMed     Abstract available


  194. LEE J, Chang CL, Lin JB, Wu MH, et al
    The Effect of Body Mass Index and Weight Change on Late Gastrointestinal Toxicity in Locally Advanced Cervical Cancer Treated With Intensity-modulated Radiotherapy.
    Int J Gynecol Cancer. 2018 Jul 10. doi: 10.1097/IGC.0000000000001312.
    PubMed     Abstract available


    June 2018
  195. DOSTALEK L, Avall-Lundqvist E, Creutzberg CL, Kurdiani D, et al
    ESGO Survey on Current Practice in the Management of Cervical Cancer.
    Int J Gynecol Cancer. 2018 Jun 28. doi: 10.1097/IGC.0000000000001314.
    PubMed     Abstract available


    May 2018
  196. NASSALI MN, Tadele M, Nkuba RM, Modimowame J, et al
    Predictors of Locally Advanced Disease at Presentation and Clinical Outcomes Among Cervical Cancer Patients Admitted at a Tertiary Hospital in Botswana.
    Int J Gynecol Cancer. 2018 May 23. doi: 10.1097/IGC.0000000000001284.
    PubMed     Abstract available


  197. KRANAWETTER M, Rohrich S, Mullauer L, Obermair H, et al
    Activity of Pembrolizumab in Recurrent Cervical Cancer: Case Series and Review of Published Data.
    Int J Gynecol Cancer. 2018 May 22. doi: 10.1097/IGC.0000000000001291.
    PubMed     Abstract available


  198. KOCAER M, Gulseren V, Ozdemir IA, Gungorduk O, et al
    Management of Vertebral Metastasis in Patients With Uterine Cervical Cancer.
    Int J Gynecol Cancer. 2018 May 4. doi: 10.1097/IGC.0000000000001273.
    PubMed     Abstract available


  199. JALLOUL RJ, Sharma S, Tung CS, O'Donnell B, et al
    Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer: A Nationwide Retrospective Cohort Study.
    Int J Gynecol Cancer. 2018 May 4. doi: 10.1097/IGC.0000000000001264.
    PubMed     Abstract available


  200. CIBULA D, Potter R, Planchamp F, Avall-Lundqvist E, et al
    The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2018;28:641-655.
    PubMed     Abstract available


  201. CIBULA D, Potter R, Planchamp F, Avall-Lundqvist E, et al
    The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2018;28:641-655.
    PubMed     Abstract available


    April 2018
  202. TOMITA N, Mizuno M, Kondo S, Mori M, et al
    Role of Extensive Lymphadenectomy in Early-Stage Cervical Cancer Patients With Radical Hysterectomy Followed by Adjuvant Radiotherapy.
    Int J Gynecol Cancer. 2018 Apr 30. doi: 10.1097/IGC.0000000000001279.
    PubMed     Abstract available


  203. CORRADO G, Vizza E, Legge F, Pedone Anchora L, et al
    Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature.
    Int J Gynecol Cancer. 2018 Apr 30. doi: 10.1097/IGC.0000000000001254.
    PubMed     Abstract available


  204. LI P, Zhang R, Nie Z, Long M, et al
    Comparison of Nedaplatin- and Cisplatin-Based Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer Patients: A Propensity Score Analysis.
    Int J Gynecol Cancer. 2018 Apr 16. doi: 10.1097/IGC.0000000000001265.
    PubMed     Abstract available


  205. WELK B, Wallis C, D'Souza D, McGee J, et al
    A Population-Based Assessment of Urologic Procedures and Operations After Surgery or Pelvic Radiation for Cervical Cancer.
    Int J Gynecol Cancer. 2018 Apr 16. doi: 10.1097/IGC.0000000000001266.
    PubMed     Abstract available


    March 2018
  206. DERKS M, van der Velden J, de Kroon CD, Nijman HW, et al
    Surgical Treatment of Early-Stage Cervical Cancer: A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period.
    Int J Gynecol Cancer. 2018 Mar 27. doi: 10.1097/IGC.0000000000001228.
    PubMed     Abstract available


  207. RYCKMAN JM, Lin C, Simone CB 2nd, Verma V, et al
    Patterns of Care for Stage IA Cervical Cancer: Use of Definitive Radiation Therapy Versus Hysterectomy.
    Int J Gynecol Cancer. 2018 Mar 20. doi: 10.1097/IGC.0000000000001225.
    PubMed     Abstract available


  208. BASU P, Mehta A, Jain M, Gupta S, et al
    A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001235.
    PubMed     Abstract available


  209. LAIOS A, Kasius J, Tranoulis A, Gryparis A, et al
    Obstetric Outcomes in Women With Early Bulky Cervical Cancer Downstaged by Neoadjuvant Chemotherapy to Allow for Fertility-Sparing Surgery: A Meta-analysis and Metaregression.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001232.
    PubMed     Abstract available


  210. MINIG L, Fagotti A, Scambia G, Salvo G, et al
    Incidence of Lymph Node Metastases in Women With Low-Risk Early Cervical Cancer (<2 cm) Without Lymph-Vascular Invasion.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001236.
    PubMed     Abstract available


  211. PLOTTI F, Terranova C, Capriglione S, Crispino S, et al
    Assessment of Quality of Life and Urinary and Sexual Function After Radical Hysterectomy in Long-Term Cervical Cancer Survivors.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001239.
    PubMed     Abstract available


  212. NAIR VB, Manasa VG, Sinto MS, Jayasree K, et al
    Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
    Int J Gynecol Cancer. 2018;28:553-562.
    PubMed     Abstract available


  213. NAIR VB, Manasa VG, Sinto MS, Jayasree K, et al
    Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
    Int J Gynecol Cancer. 2018;28:553-562.
    PubMed     Abstract available


    February 2018
  214. YOSHIHARA K, Ishiguro T, Chihara M, Shima E, et al
    The Safety and Effectiveness of Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer During Pregnancy.
    Int J Gynecol Cancer. 2018 Feb 28. doi: 10.1097/IGC.0000000000001218.
    PubMed     Abstract available


    January 2018
  215. CIMA S, Perrone AM, Castellucci P, Macchia G, et al
    Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2018 Jan 24. doi: 10.1097/IGC.0000000000001207.
    PubMed     Abstract available


  216. O'DONNELL B, Shiao JC, Pezzi TA, Waheed N, et al
    Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.
    Int J Gynecol Cancer. 2018 Jan 10. doi: 10.1097/IGC.0000000000001200.
    PubMed     Abstract available


  217. CHONG GO, Lee YH, Lee HJ, Hong DG, et al
    Comparison of the Long-Term Oncological Outcomes Between the Initial Learning Period of Robotic and the Experienced Period of Laparoscopic Radical Hysterectomy for Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2018 Jan 4. doi: 10.1097/IGC.0000000000001172.
    PubMed     Abstract available


  218. KOJIMA A, Shimada M, Mikami Y, Nagao S, et al
    Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group.
    Int J Gynecol Cancer. 2018;28:99-106.
    PubMed     Abstract available


  219. HOU WH, Schultheiss TE, Wong JY, Wakabayashi MT, et al
    Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.
    Int J Gynecol Cancer. 2018;28:188-193.
    PubMed     Abstract available


    November 2017
  220. KIM H, Kim YS, Joo JH, Eom KY, et al
    Tumor Boost Using External Beam Radiation in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy: Outcome From a Multicenter Retrospective Study (Korean Radiation Oncology Group 1419).
    Int J Gynecol Cancer. 2017 Nov 17. doi: 10.1097/IGC.0000000000001155.
    PubMed     Abstract available


    October 2017
  221. KIYOTOKI T, Nakamura K, Haraga J, Omichi C, et al
    Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
    Int J Gynecol Cancer. 2017 Oct 17. doi: 10.1097/IGC.0000000000001127.
    PubMed     Abstract available


  222. WEI WF, Han LF, Liu D, Wu LF, et al
    Orthotopic Xenograft Mouse Model of Cervical Cancer for Studying the Role of MicroRNA-21 in Promoting Lymph Node Metastasis.
    Int J Gynecol Cancer. 2017;27:1587-1595.
    PubMed     Abstract available


  223. HILLESHEIM I, Limone GA, Klimann L, Monego H, et al
    Cervical Cancer Posttreatment Follow-up: Critical Analysis.
    Int J Gynecol Cancer. 2017;27:1747-1752.
    PubMed     Abstract available


  224. LI X, Wang L, Li Y, Song P, et al
    The Value of Diffusion-Weighted Imaging in Combination With Conventional Magnetic Resonance Imaging for Improving Tumor Detection for Early Cervical Carcinoma Treated With Fertility-Sparing Surgery.
    Int J Gynecol Cancer. 2017;27:1761-1768.
    PubMed     Abstract available


    September 2017
  225. AL-HARBI NM, Bin Judia SS, Mishra KN, Shoukri MM, et al
    Genetic Predisposition to Cervical Cancer and the Association With XRCC1 and TGFB1 Polymorphisms.
    Int J Gynecol Cancer. 2017 Sep 13. doi: 10.1097/IGC.0000000000001103.
    PubMed     Abstract available


  226. TAKIUCHI T, Machida H, Hom MS, Mostofizadeh S, et al
    Association of Metformin Use and Survival Outcome in Women With Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:1455-1463.
    PubMed     Abstract available


  227. CHENG J, Hou Y, Li J, Wang W, et al
    Agreement Between Magnetic Resonance Imaging and Pathologic Findings in the Tumor Size Evaluation Before and After Neoadjuvant Chemotherapy Treatment: A Prospective Study.
    Int J Gynecol Cancer. 2017;27:1472-1479.
    PubMed     Abstract available


  228. LUO L, Zhang H, Nian S, Lv C, et al
    Up-regulation of Transcription Factor 3 Is Correlated With Poor Prognosis in Cervical Carcinoma.
    Int J Gynecol Cancer. 2017;27:1422-1430.
    PubMed     Abstract available


  229. LUAN T, Hua Q, Liu X, Xu P, et al
    PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies.
    Int J Gynecol Cancer. 2017;27:1480-1488.
    PubMed     Abstract available


    August 2017
  230. NIE JC, Yan AQ, Liu XS
    Robotic-Assisted Radical Hysterectomy Results in Better Surgical Outcomes Compared With the Traditional Laparoscopic Radical Hysterectomy for the Treatment of Cervical Cancer.
    Int J Gynecol Cancer. 2017 Aug 31. doi: 10.1097/IGC.0000000000001101.
    PubMed     Abstract available


    July 2017
  231. LUCIDI A, Windemut S, Petrillo M, Dessole M, et al
    Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001045.
    PubMed     Abstract available


  232. CHANTALAT E, Vidal F, Motton S
    Letter to the Editor on "Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer": What is the Best Approach? Int J Gynecol Cancer. 2017 Mar; 27(3): 543549.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001085.
    PubMed    


  233. NARTEY Y, Hill PC, Amo-Antwi K, Nyarko KM, et al
    Factors Contributing to the Low Survival Among Women With a Diagnosis of Invasive Cervical Cancer in Ghana.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001088.
    PubMed     Abstract available


  234. PANG T, Li M, Zhang Y, Yong W, et al
    Y Box-Binding Protein 1 Promotes Epithelial-Mesenchymal Transition, Invasion, and Metastasis of Cervical Cancer via Enhancing the Expressions of Snail.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001066.
    PubMed     Abstract available


  235. VAN GENT MDJM, Rademaker M, van der Veer JCB, van Poelgeest MIE, et al
    Long-Term Oncological Outcome After Conventional Radical Hysterectomy Versus 2 Nerve-Sparing Modalities for Early Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jul 12. doi: 10.1097/IGC.0000000000001067.
    PubMed     Abstract available


  236. MACHIDA H, Eckhardt SE, Antonio C, Blake EA, et al
    Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States.
    Int J Gynecol Cancer. 2017 Jul 12. doi: 10.1097/IGC.0000000000001068.
    PubMed     Abstract available


  237. ZHU T, Chen X, Zhu J, Chen Y, et al
    Surgical and Pathological Outcomes of Laparoscopic Versus Abdominal Radical Hysterectomy With Pelvic Lymphadenectomy and/or Para-aortic Lymph Node Sampling for Bulky Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:1222-1227.
    PubMed     Abstract available


  238. JUNG EJ, Byun JM, Kim YN, Lee KB, et al
    Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:1228-1236.
    PubMed     Abstract available


  239. HONG MK, Wang JH, Su CC, Li MH, et al
    Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:1247-1255.
    PubMed     Abstract available


    June 2017
  240. SONG MK, Shin BS, Ha CS, Park WY, et al
    Would Lipophilic Statin Therapy as a Prognostic Factor Improve Survival in Patients With Uterine Cervical Cancer?
    Int J Gynecol Cancer. 2017 Jun 23. doi: 10.1097/IGC.0000000000001046.
    PubMed     Abstract available


  241. CANAZ E, Ozyurek ES, Erdem B, Aldikactioglu Talmac M, et al
    Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jun 14. doi: 10.1097/IGC.0000000000001060.
    PubMed     Abstract available


  242. POKA R, Molnar S, Darago P, Lukacs J, et al
    Intention-to-Treat Analysis of Radical Trachelectomy for Early-Stage Cervical Cancer With Special Reference to Oncologic Failures: Single-Institutional Experience in Hungary.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001048.
    PubMed     Abstract available


  243. GULER OC, Sari SY, Birgi SD, Gultekin M, et al
    Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001029.
    PubMed     Abstract available


  244. ECHEVERRIA A, Manley H, O'Donnell B, Asper J, et al
    Factors Associated With Radiation Treatment Compliance for Women With Cervical Cancer in a Safety Net Health System.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001035.
    PubMed     Abstract available


  245. SALIHI R, Leunen K, Moerman P, Amant F, et al
    Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jun 1. doi: 10.1097/IGC.0000000000001021.
    PubMed     Abstract available


  246. YANG L, Zheng A, Zhang X, Fang X, et al
    Clear Cell Carcinoma of the Uterine Cervix: A Clinical and Pathological Analysis of 47 Patients Without Intrauterine Diethylstilbestrol Exposure.
    Int J Gynecol Cancer. 2017;27:1009-1014.
    PubMed     Abstract available


  247. LIU CZ, Zeng HX, Zhao JJ, Rong Y, et al
    The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Int J Gynecol Cancer. 2017;27:994-1000.
    PubMed     Abstract available


    May 2017
  248. DERKS M, Groenman FA, van Lonkhuijzen LRCW, Schut PC, et al
    Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000974.
    PubMed     Abstract available


  249. BAKKER RM, Pieterse QD, van Lonkhuijzen LRCW, Trimbos BJBMZ, et al
    A Controlled Study on Vaginal Blood Flow During Sexual Arousal Among Early-Stage Cervical Cancer Survivors Treated With Conventional Radical or Nerve-Sparing Surgery With or Without Radiotherapy.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000986.
    PubMed     Abstract available


  250. PLANTE M, Renaud MC, Sebastianelli A, Gregoire J, et al
    Simple Vaginal Trachelectomy: A Valuable Fertility-Preserving Option in Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000989.
    PubMed     Abstract available


  251. ZHENG RR, Huang XW, Liu WY, Lin RR, et al
    Nomogram Predicting Overall Survival in Operable Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000987.
    PubMed     Abstract available


  252. TOMAO F, Maruccio M, Preti EP, Boveri S, et al
    Conization in Early Stage Cervical Cancer: Pattern of Recurrence in a 10-Year Single-Institution Experience.
    Int J Gynecol Cancer. 2017 May 8. doi: 10.1097/IGC.0000000000000991.
    PubMed     Abstract available


  253. WEN Q, Liu Y, Lyu H, Xu X, et al
    Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Int J Gynecol Cancer. 2017 May 2. doi: 10.1097/IGC.0000000000001028.
    PubMed     Abstract available


  254. DEVOR EJ, Reyes HD, Gonzalez-Bosquet J, Warrier A, et al
    Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology.
    Int J Gynecol Cancer. 2017;27:784-790.
    PubMed     Abstract available


    April 2017
  255. ROSEN VM, Guerra I, McCormack M, Nogueira-Rodrigues A, et al
    Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer.
    Int J Gynecol Cancer. 2017 Apr 26. doi: 10.1097/IGC.0000000000001000.
    PubMed     Abstract available


    March 2017
  256. ZHANG Y, Gao H, Gao X, Huang S, et al
    Elevated Expression of Kin17 in Cervical Cancer and Its Association With Cancer Cell Proliferation and Invasion.
    Int J Gynecol Cancer. 2017 Mar 24. doi: 10.1097/IGC.0000000000000928.
    PubMed     Abstract available


  257. LEE JW, Jeon S, Mun ST, Lee SM, et al
    Prognostic Value of Fluorine-18 Fluorodeoxyglucose Uptake of Bone Marrow on Positron Emission Tomography/Computed Tomography for Prediction of Disease Progression in Cervical Cancer.
    Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000949.
    PubMed     Abstract available


  258. WANG Q, Wei Y, Zhang J
    Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer.
    Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000951.
    PubMed     Abstract available


  259. LIU ZS, Guo J, Zhao YZ, Lin X, et al
    Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Int J Gynecol Cancer. 2017 Mar 6. doi: 10.1097/IGC.0000000000000929.
    PubMed     Abstract available


  260. GUNTUPALLI SR, Sheeder J, Ioffe Y, Tergas A, et al
    Sexual and Marital Dysfunction in Women With Gynecologic Cancer.
    Int J Gynecol Cancer. 2017;27:603-607.
    PubMed     Abstract available


    February 2017
  261. GUBBI A, Kacheria S, Ahmad S, Stavitzski NM, et al
    Prognostic Significance of the Standardized Uptake Value of Pretherapeutic 18F-Labeled 2-Fluoro-2-Deoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Locally Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000930.
    PubMed     Abstract available


  262. MABUCHI S, Kimura T
    Extraperitoneal Radical Trachelectomy With Pelvic Lymphadenectomy: A Novel Fertility-Preserving Option for Early Stage Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000918.
    PubMed     Abstract available


  263. KOENSGEN D, Sehouli J, Belau A, Weiss M, et al
    Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000894.
    PubMed     Abstract available


  264. PETITNICOLAS C, Azais H, Ghesquiere L, Tresch-Bruneel E, et al
    Morbidity of Staging Inframesenteric Paraaortic Lymphadenectomy in Locally Advanced Cervical Cancer Compared With Infrarenal Lymphadenectomy.
    Int J Gynecol Cancer. 2017 Feb 4. doi: 10.1097/IGC.0000000000000921.
    PubMed     Abstract available


  265. KIM M, Suh DH, Kim K, Lee HJ, et al
    Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:332-338.
    PubMed     Abstract available


  266. GUO X, Dong Z, Yamada S, Li Y, et al
    Association of Casp3 microRNA Target Site (1049216) SNP With the Risk and Progress of Cervical Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:206-213.
    PubMed     Abstract available


  267. HARTMAN CA, Teixeira JC, Barbosa SB, Figueiredo SM, et al
    Analysis of Conservative Surgical Treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years.
    Int J Gynecol Cancer. 2017;27:357-363.
    PubMed     Abstract available


    January 2017
  268. YANG K, Park W, Huh SJ, Park BK, et al
    Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 Jan 26. doi: 10.1097/IGC.0000000000000909.
    PubMed     Abstract available


  269. BOGANI G, Ditto A, Martinelli F, Signorelli M, et al
    Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery.
    Int J Gynecol Cancer. 2017 Jan 26. doi: 10.1097/IGC.0000000000000902.
    PubMed     Abstract available


  270. NEGRAO MV, Lima JM, Silva SC, Diz MD, et al
    Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?
    Int J Gynecol Cancer. 2017 Jan 19. doi: 10.1097/IGC.0000000000000914.
    PubMed     Abstract available


  271. SLAMA J, Fischerova D, Zikan M, Kocian R, et al
    Sensitivity of Follow-Up Methods in Patients After Fertility-Sparing Surgery for Cervical Cancers.
    Int J Gynecol Cancer. 2017;27:147-153.
    PubMed     Abstract available


    December 2016
  272. SASAKI Y, Iwanari O, Arakawa I, Moriya T, et al
    Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.
    Int J Gynecol Cancer. 2016 Dec 16. doi: 10.1097/IGC.0000000000000898.
    PubMed     Abstract available


  273. CHEN X, Zou H, Li H, Lin R, et al
    Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer: A Meta-Analysis.
    Int J Gynecol Cancer. 2016.
    PubMed     Abstract available


  274. DERKS M, van Lonkhuijzen LR, Bakker RM, Stiggelbout AM, et al
    Long-Term Morbidity and Quality of Life in Cervical Cancer Survivors: A Multicenter Comparison Between Surgery and Radiotherapy as Primary Treatment.
    Int J Gynecol Cancer. 2016.
    PubMed     Abstract available


  275. GRAVES S, Seagle BL, Strohl AE, Shahabi S, et al
    Survival After Pelvic Exenteration for Cervical Cancer: A National Cancer Database Study.
    Int J Gynecol Cancer. 2016.
    PubMed     Abstract available


  276. KIM YJ, Kim BR, Ryu JS, Lee GO, et al
    HNRNPA1, a Splicing Regulator, Is an Effective Target Protein for Cervical Cancer Detection: Comparison With Conventional Tumor Markers.
    Int J Gynecol Cancer. 2016.
    PubMed     Abstract available


  277. EMMETT M, Gildea C, Nordin A, Hirschowitz L, et al
    Variations in Treatment of Cervical Cancer According to Tumor Morphology-Population-Based Cohort Analysis of English National Cancer Registration Data.
    Int J Gynecol Cancer. 2016.
    PubMed     Abstract available


    November 2016
  278. HANPRASERTPONG J, Jiamset I, Geater A, Peerawong T, et al
    The Effect of Metformin on Oncological Outcomes in Patients With Cervical Cancer With Type 2 Diabetes Mellitus.
    Int J Gynecol Cancer. 2016.
    PubMed     Abstract available


  279. SUN P, Shen Y, Gong JM, Zhou LL, et al
    A New MicroRNA Expression Signature for Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Abstract available


    October 2016
  280. DIAB Y
    Sentinel Lymph Nodes Mapping in Cervical Cancer a Comprehensive Review.
    Int J Gynecol Cancer. 2016.
    PubMed     Abstract available


    September 2016
  281. NAKAMURA K, Masuyama H, Ida N, Haruma T, et al
    Radical Hysterectomy Plus Concurrent Chemoradiation/Radiation Therapy Is Negatively Associated With Return to Work in Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Abstract available


  282. LEE KC, Kim HJ, Sung K, Choi YE, et al
    The Predictive Value of Tumor Size, Volume, and Markers During Radiation Therapy in Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Abstract available


  283. ZUSTERZEEL PL, Pol FJ, van Ham M, Zweemer RP, et al
    Vaginal Radical Trachelectomy for Early-Stage Cervical Cancer: Increased Recurrence Risk for Adenocarcinoma.
    Int J Gynecol Cancer. 2016;26:1293-9.
    PubMed     Abstract available


  284. RYCHLIK A, Marin S, De Santiago J, Zapardiel I, et al
    Utility of Laparoscopic Indocyanine Green-Guided Sentinel Node Biopsy in Open Cervical Cancer Surgery.
    Int J Gynecol Cancer. 2016;26:1288-9.
    PubMed     Abstract available


  285. MABUCHI S, Yokoi E, Owa T, Kozasa K, et al
    Phase I Clinical Study of Irinotecan Plus S-1 in Patients With Advanced or Recurrent Cervical Cancer Previously Treated With Platinum-Based Chemotherapy.
    Int J Gynecol Cancer. 2016;26:1281-7.
    PubMed     Abstract available


  286. WANG W, Chu HJ, Shang CL, Gong X, et al
    Long-Term Oncological Outcomes After Laparoscopic Versus Abdominal Radical Hysterectomy in Stage IA2 to IIA2 Cervical Cancer: A Matched Cohort Study.
    Int J Gynecol Cancer. 2016;26:1264-73.
    PubMed     Abstract available


    March 2016
  287. ABDALLAH R, Bush SH, Chon HS, Apte SM, et al
    Therapeutic Dilemma: Prognostic Factors and Outcome for Neuroendocrine Tumors of the Cervix.
    Int J Gynecol Cancer. 2016;26:553-60.
    PubMed     Abstract available


  288. SATO S, Shimada M, Ohta T, Kojimahara T, et al
    Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients With Uterine Cervical Non-Squamous Cell Carcinoma After Radical Hysterectomy.
    Int J Gynecol Cancer. 2016;26:561-7.
    PubMed     Abstract available


  289. HAO M, Wang Z, Wei F, Wang J, et al
    Cavitron Ultrasonic Surgical Aspirator in Laparoscopic Nerve-Sparing Radical Hysterectomy: A Pilot Study.
    Int J Gynecol Cancer. 2016;26:594-9.
    PubMed     Abstract available


  290. ALCAZAR JL, Arribas S, Martinez-Monge R, Jurado M, et al
    Three-Dimensional Power Doppler Ultrasound for Predicting Response and Local Recurrence After Concomitant Chemoradiation Therapy for Locally Advanced Carcinoma of the Cervix.
    Int J Gynecol Cancer. 2016;26:534-8.
    PubMed     Abstract available


    February 2016
  291. ZHOU G, Chen X, Tang F, Zhou J, et al
    The Value of Diffusion-Weighted Imaging in Predicting the Prognosis of Stage IB-IIA Cervical Squamous Cell Carcinoma After Radical Hysterectomy.
    Int J Gynecol Cancer. 2016;26:361-6.
    PubMed     Abstract available


  292. VRANES B, Milenkovic S, Radojevic M, Soldatovic I, et al
    Risk of Parametrial Spread in Small Stage I Cervical Carcinoma: Pathology Review of 223 Cases With a Tumor Diameter of 20 mm or Less.
    Int J Gynecol Cancer. 2016;26:416-21.
    PubMed     Abstract available


    January 2016
  293. LEBLANC E, Katdare N, Narducci F, Bresson L, et al
    Should Systematic Infrarenal Para-aortic Dissection Be the Rule in the Pretherapeutic Staging of Primary or Recurrent Locally Advanced Cervix Cancer Patients With a Negative Preoperative Para-aortic PET Imaging?
    Int J Gynecol Cancer. 2016;26:169-75.
    PubMed     Abstract available


  294. SHI R, Wei W, Jiang P
    Laparoscopic Nerve-Sparing Radical Hysterectomy for Cervical Carcinoma: Emphasis on Nerve Content in Removed Cardinal Ligaments.
    Int J Gynecol Cancer. 2016;26:192-8.
    PubMed     Abstract available


  295. KI EY, Lee KH, Hur SY, Rhee JE, et al
    Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
    Int J Gynecol Cancer. 2016;26:176-83.
    PubMed     Abstract available


  296. CHANG WC, Li CH, Chu LH, Huang PS, et al
    Regulatory T Cells Suppress Natural Killer Cell Immunity in Patients With Human Cervical Carcinoma.
    Int J Gynecol Cancer. 2016;26:156-62.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: